Results 1 to 10 of about 1,712 (210)

Asthma in Patients With Japanese Cedar Pollinosis [PDF]

World Allergy Organization Journal, 2012
Japanese cedar pollen is the most common causative allergen for seasonal allergic rhinitis (AR) in Japan. More commonly known as Japanese cedar pollinosis, it occurs in spring causing the typical symptoms of seasonal AR, such as sneezing, rhinorrhea ...
Akihiko Tanaka, Kenji Minoguchi, Ruby Pawankar, Mitsuru Adachi   +3 more
doaj   +5 more sources

Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status [PDF]

Pathogens, 2022
The incidence of Japanese cedar pollinosis is increasing significantly in Japan, and a recent survey suggested that about 40% of the population will develop this disease. However, spontaneous remission is rare.
Daiju Sakurai, Hiroki Ishii, Ayumi Shimamura, Daisuke Watanabe, Takaaki Yonaga, Tomokazu Matsuoka   +5 more
doaj   +2 more sources

Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis [PDF]

Pathogens, 2022
Sublingual immunotherapy for Japanese cedar pollinosis can improve the symptoms of allergic rhinitis and modify its natural course. However, sublingual immunotherapy requires a long treatment period and some patients do not respond to treatment.
Riyo Yoneda, Tomohisa Iinuma, Daiju Sakurai, Junya Kurita, Tomoyuki Arai, Yuri Sonobe, Syuji Yonekura, Yoshitaka Okamoto, Toyoyuki Hanazawa   +8 more
doaj   +2 more sources

Allergen‐specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season [PDF]

Immunity, Inflammation and Disease, 2020
Background and objective Nasal symptoms of allergic rhinitis can be reduced with allergen‐specific subcutaneous immunotherapy (SCIT). However, the mechanisms underlying the effectiveness of SCIT for Japanese cedar pollinosis are not well understood.
Kuninori Otsuka, Hirokuni Otsuka, Shoji Matsune, Kimihiro Okubo   +3 more
doaj   +2 more sources

Next-Generation Allergen-Specific Immunotherapy for Japanese Cedar Pollinosis Using Molecular Approaches [PDF]

ImmunoTargets and Therapy, 2021
Fumio Takaiwa1,2 1Soul Signal Institute, Kojyohama, Shiraoi, Hokkaido, 059-0641, Japan; 2Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Tsukuba, Ibaraki, 305-8602, JapanCorrespondence: Fumio TakaiwaInstitute of
Takaiwa F
doaj   +2 more sources

Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy [PDF]

Immunity, Inflammation and Disease, 2020
Background and Objective Nasal symptoms were reduced following allergen‐specific sublingual immunotherapy (SLIT) for allergic rhinitis. The mechanisms underlying the effectiveness of SLIT for Japanese cedar pollinosis are poorly understood.
Kuninori Otsuka, Hirokuni Otsuka, Shoji Matsune, Kimihiro Okubo   +3 more
doaj   +2 more sources

Are Respiratory Viruses Involved in Preseasonal Symptoms or Severity in Japanese Cedar Pollinosis? [PDF]

Allergy & Rhinology, 2016
Background Respiratory virus infections are involved in asthma exacerbations. However, there are no reports of the relationship between respiratory virus infections and Japanese cedar pollinosis.
Hirokuni Otsuka M.D., Hiroyuki Tsukagoshi Ph.D., Hirokazu Kimura M.D., Ikuo Takanashi Ph.D., Kimihiro Okubo M.D.   +4 more
doaj   +2 more sources

Solid-in-Oil Nanodispersions for Transcutaneous Immunotherapy of Japanese Cedar Pollinosis [PDF]

Pharmaceutics, 2020
Japanese cedar pollinosis (JCP) is a common affliction caused by an allergic reaction to cedar pollen and is considered a disease of national importance in Japan.
Qingliang Kong, Momoko Kitaoka, Rie Wakabayashi, Yoshiro Tahara, Noriho Kamiya, Masahiro Goto   +5 more
doaj   +2 more sources

Real-world efficacy of sublingual immunotherapy with Japanese cedar pollen for cypress pollinosis [PDF]

Journal of Allergy and Clinical Immunology: Global
Background: It remains unclear whether allergen immunotherapy with Japanese cedar pollen extract is effective for Japanese cypress pollinosis in real-world settings. Objective: We sought to investigate the Japan-wide prevalence of cypress pollinosis, the
Aiko Oka, MD, Tamami Yamashita, MD, Kengo Kanai, MD, Atsushi Yuta, MD, Yukiko Ogawa, MD, Eriko Takahara, MD, Hideki Shiratsuchi, MD, Akihiko Terada, MD, Takatsugu Tsunoda, MD, Takeshi Masuda, MD, Satoru Masuno, MD, Kenichi Kanai, MD, Hitoshi Nagakura, MD, Reiko Tokuda, MD, Harumi Arao, MD, Hitoshi Bamba, MD, Shigenobu Yasuda, MD, Hideya Mimura, MD, Mahoko Nakazato, MD, Hidehisa Nakazato, MD, Noriyuki Houya, MD, Hideaki Tsuzuki, MD, Masaharu Tokuriki, MD, Mayuko Sakaida, MD, Ryo Amesara, MD, Chikahisa Ohkawa, MD, Takemitsu Hama, MD, Hiroki Ikeda, MD, Hisaki Fukushima, MD, Sumiko Niitsu, MD, Hirofumi Sakaguchi, MD, Norihito Iba, MD, Hiroshi Kumanomidou, MD, Yoshiyuki Hyo, MD, Ryo Takagi, MD, Takashi Koike, MD, Marie Yamada, MD, Mitsuhiro Okano, MD   +37 more
doaj   +2 more sources

Intake of a fermented plant product attenuates allergic symptoms without changing systemic immune responses in a mouse model of Japanese cedar pollinosis [PDF]

World Allergy Organization Journal, 2018
Background Japanese cedar pollinosis (JCP) is one of the most prevalent allergies in Japan. Within the past few decades, many food factors have been demonstrated to suppress symptoms of pollinosis and mast cell degranulation directly or indirectly ...
Takashi Fujimura, Ayane Hori, Hideto Torii, Shinsuke Kishida, Yoshinori Matsuura, Seiji Kawamoto   +5 more
doaj   +2 more sources